Authors

• Sanjiv J. Shah (ORCID: https://orcid.org/0000-0002-5655-8201)
• Brian Lee Claggett (ORCID: https://orcid.org/0000-0002-4215-9218)
• Maria A. Pabón (ORCID: https://orcid.org/0000-0003-1883-0654)
• Pardeep S. Jhund (ORCID: https://orcid.org/0000-0003-4306-5317)
• James Lay‐Flurrie
• John J.V. McMurray (ORCID: https://orcid.org/0000-0002-6317-3975)
• Bertram Pitt (ORCID: https://orcid.org/0000-0001-5880-275X)
• Muthiah Vaduganathan (ORCID: https://orcid.org/0000-0003-0885-1953)
• Andrea Lage
• Carolyn S.P. Lam (ORCID: https://orcid.org/0000-0003-1903-0018)
• Jonathan W. Cunningham (ORCID: https://orcid.org/0000-0003-4481-7867)
• Michele Senni
• Akshay S. Desai (ORCID: https://orcid.org/0000-0002-1443-0701)
• Adriaan A. Voors
• Markus F. Scheerer
• Scott Solomon
• Faiez Zannad
• Flaviana Amarante

Institutions

• Northwestern University (US)
• Brigham and Women's Hospital (US)
• National University of Singapore (SG)
• University of Groningen (NL)
• University of Michigan (US)
• British Heart Foundation (GB)
• Ospedale Papa Giovanni XXIII (IT)
• National University Heart Centre Singapore (SG)
• National Heart Centre Singapore (SG)
• Bayer (United Kingdom) (GB)
• University of Milano-Bicocca (IT)
• Bayer (Germany) (DE)
• University of Glasgow (GB)
• Université de Lorraine (FR)

Publication Details

Journal

JAMA Cardiology

Published

2025-03-30

DOI

https://doi.org/10.1001/jamacardio.2025.0860

Citations

6

Primary Topic

Heart Failure Treatment and Management

Type

article

Field-Weighted Citation Impact

8.33

Funders

• American Heart Association
• Amgen
• Eli Lilly and Company
• AstraZeneca
• Bayer
• Alnylam Pharmaceuticals
• Cytokinetics
• British Heart Foundation
• University of Glasgow
• Novo Nordisk
• National Institutes of Health
• American Regent
• Medical Research Council
• National Medical Research Council
• National Heart, Lung, and Blood Institute